T 0256/18 (Lixisenatide in combination with sulfonylurea/SANOFI) of 14.10.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T025618.20211014
- Date of decision
- 14 October 2021
- Case number
- T 0256/18
- Petition for review of
- -
- Application number
- 12712106.9
- IPC class
- A61K 38/26A61K 31/64A61P 3/08
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Prevention of hypoglycaemia in diabetes mellitus type 2 patients
- Applicant name
- Sanofi-Aventis Deutschland GmbH
- Opponent name
- Generics (U.K.) Limited
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - agreement to text of the patent as granted withdrawn by patent proprietor
Basis of decision - patent revoked - Catchword
- -
- Cited cases
- T 0073/84
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.